Skip to Main Content

Paper Details

Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration: Results From the IRIS Registry and Komodo Healthcare Map.
JAMA Ophthalmol
57
2022
Author NameAffiliation
Thomas A AlbiniBascom Palmer Eye Institute
  • 1 - 1

Datasets

Release 1.2